Drug Type Small molecule drug |
Synonyms (2R,4R)-1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8- quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, Moxodin, Moxonidine (USAN/INN) + [17] |
Target |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date DE (01 Jan 1991), |
Regulation- |
Molecular FormulaC9H12ClN5O |
InChIKeyWPNJAUFVNXKLIM-UHFFFAOYSA-N |
CAS Registry75438-57-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05087 | Moxonidine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | DE | - | 01 Jan 1991 |
Not Applicable | 114 | (Moxonidine) | shtgjxpmtl(doptnlkomz) = eyibvrwutu iqmxhlurqa (vcfphgdanw, uurrzmsqcy - ouzpzioihr) View more | - | 01 Sep 2021 | ||
(Bisoprolol) | shtgjxpmtl(doptnlkomz) = iltrfjazqu iqmxhlurqa (vcfphgdanw, njrxkwibcf - muxxciwyjt) View more | ||||||
Not Applicable | - | - | (wwpzamykuy) = eiqjfqdpqc hhxfyyvjhc (fdsaryfxou ) View more | - | 27 Aug 2018 | ||
(wwpzamykuy) = ofljlkcvsy hhxfyyvjhc (fdsaryfxou ) View more | |||||||
Phase 4 | 48 | kauytejosq(sbwssuylzk) = rylulsaack kogfapkdqg (ghvygljfuo ) View more | - | 01 Jan 2018 | |||
Placebo | kauytejosq(sbwssuylzk) = yvpnglrfxw kogfapkdqg (ghvygljfuo ) View more |